Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Candel Therapeutics, Inc. (CADL)

NASDAQ

$12,72

$--

(0,00%)

Pre-Market

Candel Therapeutics, Inc. (CADL) Live Price Chart

Last updated: ⁦2026-09-09 09:50:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Candel Therapeutics, Inc. (CADL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $12,72, with a market capitalization of $977,91M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,35 to $14,00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$977,91M
Open	$12,72
Day's High	$14,78
Day's Low	$0,66
Previous Close	$12,60
Volume	18,00
Average Volume	1,51M
P/E Ratio	--
52-Week High	$14,00
52-Week Low	$4,35
Dividend Yield	--
Earnings Date	--

Candel Therapeutics, Inc. (CADL) Pre-Market Stock Price

Candel Therapeutics, Inc. (CADL) is trading at $12,72 in pre-market trading as of 2026-09-09 09:43:00, up 0,91% ($0,12) from the previous close of $12,60

Pre-market trading shows how investors are pricing CADL before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Candel Therapeutics, Inc. (CADL) 7-Day Stock Price Change

Over the past seven days, Candel Therapeutics, Inc. (CADL) moved from $13,07 to $12,72, representing a decline of 2,72% ($0,36).

The stock traded between $12,02 and $13,80 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 863,03 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CADL 52-Week Price Position

Position in Range: 86,7%

52W Low$4,35

52W High$14,00

CADL is currently trading at $12,72, placing it 86,7% of the way from its 52-week low of $4,35 to its 52-week high of $14,00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Candel Therapeutics, Inc. (CADL)?

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Candel Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	55
Exchange	NASDAQ
Company Website	https://www.candeltx.com

How to Buy Candel Therapeutics, Inc. (CADL) Stock on MEXC

Eligible investors can buy real shares of Candel Therapeutics, Inc. (CADL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CADL and Place Your Order

Open the RealStocks trading page and search for CADL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Candel Therapeutics, Inc. (CADL) stock price today?

Candel Therapeutics, Inc. (CADL) is currently trading at $ 12,72, up 0,91% ($0,12) from the previous close of $ 12,60. Intraday prices update in real time during regular trading hours.

2.Is CADL stock going up or down today?

As of 2026-09-09 09:43:00, CADL is trading at $ 12,72, up 0,91% ($0,12) from its previous close of $ 12,60. The stock has traded between $ 0,66 and $ 14,78 during today’s regular session. Past price movements do not guarantee future results.

3.What is CADL pre-market price?

As of 2026-09-09 09:43:00, CADL is trading at $ 12,72 in pre-market trading, up 0,91% ($0,12) from the previous close of $ 12,60. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CADL after-hours price?

As of 2026-09-09 09:43:00, CADL is trading at $ 12,72 in after-hours trading, up 0,91% ($0,12) from the regular-session close of $ 12,60. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CADL stock trading now?

CADL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CADL sit relative to its 52-week high and low?

Over the past 52 weeks, CADL has traded between a low of $ 4,35 and a high of $ 14,00. At $ 12,72, the stock is positioned 86,7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Candel Therapeutics, Inc. in?

Candel Therapeutics, Inc. (CADL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Candel Therapeutics, Inc.'s market capitalization and where is it listed?

Candel Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 977,91M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CADL valued in terms of P/E ratio and EPS?

CADL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,16. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Candel Therapeutics, Inc. pay a dividend?

Candel Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.